Clinical Trial Update: Weekly and Every 3 Week Administration of Paclitaxel Liposome Injection in Metastatic Breast Cancer [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update examines weekly versus every-three-week administration of paclitaxel liposome injection for metastatic breast cancer; the cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Paclitaxel liposome injection (paclitaxel liposome)

Snippet

Sponsor: Nanjing Luye Sike Pharmaceutical Co., Ltd. | Conditions: Breast Cancer | Phase 4 | Status: UNKNOWN